Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ · Healthcare
Recursion Pharmaceuticals, Inc. Total Liabilities 2019–2025
Recursion Pharmaceuticals, Inc. annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Recursion Pharmaceuticals, Inc. total liabilities as of December 31, 2025: 343.3M, a 17.05% decrease year-over-year.
- Recursion Pharmaceuticals, Inc. total liabilities for 2025 were 343.3M, a 17.05% decrease from 2024.
- Recursion Pharmaceuticals, Inc. total liabilities for 2024 were 413.8M, a 117.50% increase from 2023.
- Recursion Pharmaceuticals, Inc. total liabilities for 2023 were 190.3M, a 11.70% decrease from 2022.
- Recursion Pharmaceuticals, Inc. total liabilities for 2022 were 215.5M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Recursion Pharmaceuticals, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $343 |
| 2024 | $414 |
| 2023 | $190 |
| 2022 | $215 |
| 2021 | $67 |
| 2020 | $57 |
Recursion Pharmaceuticals, Inc. Total Liabilities — FAQ
Recursion Pharmaceuticals, Inc. (RXRX) total liabilities over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RXRX's total liabilities history?
The chart and table above show Recursion Pharmaceuticals, Inc.'s total liabilities by year and by quarter, including the growth rate.